Today, he continues to live an active life as a dedicated patient advocate, raising awareness of neuroendocrine tumors and promoting the importance of scaling patient access to Theranostics worldwide. As a co-founder of the Neuroendocrine Cancer Foundation, Josh reflects on the importance of continued investment in research and patient-centered innovation to improve outcomes for cancer patients worldwide.